X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0%
Tue, 5 Feb

GSK PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

GSK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m7,0398,1638,2541.1%17.3%
Other incomeRs m12014816410.8%37.4%
TurnoverRs m7,1598,3118,4181.3%17.6%
ExpensesRs m5,6216,5126,8805.7%22.4%
Gross profitRs m1,4181,5341,6557.9%16.7%
DepreciationRs m1341151204.7%-10.0%
InterestRs m021-77.3%0.0%
Profit before taxRs m1,4041,5651,6988.5%20.9%
TaxRs m5075575682.0%12.1%
Profit after taxRs m8971,0081,13012.1%26.0%
Gross profit margin%20.118.820.0
Effective tax rate%36.135.633.5
Net profit margin%12.512.113.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 17.3% on a year-on-year (YoY) basis. The expenses were up by 22.4% YoY during the same period.
  • The company's operating profit increased by 16.7% YoY during the quarter. Consequently, operating profit margins remained same and stood at 20.0% in 3QFY19.
  • Depreciation charges declined by 10.0% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 37.4% YoY during the quarter.
  • Net profit for the quarter increased by 26.0% YoY. Net profit margins during the quarter increased from 12.5% in 3QFY18 to 13.4% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 1.1% on a quarter-on-quarter (QoQ) basis. The expenses were up by 5.7% QoQ during the same period.
  • The company's operating profit increased by 7.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.0% in 3QFY19 as against 18.8% in 2QFY18.
  • Net profit for the quarter increased by 12.1% QoQ, while net profit margins increased from 12.1% in 2QFY18 to 13.4% in 3QFY19.

To see how GSK PHARMA has performed over the last eight quarters, please visit here.

GSK PHARMA Share Price Performance

Over the last one year, GSK PHARMA share price has moved up from Rs 1,230.6 to Rs 1,401.3, registering a Gain of Rs 170.7 or around 13.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,893.6 (up 0.6%). Over the last one year it has moved down from 14,075.0 to 13,893.6, a gain of 181 points (down 1.3%).

Overall, the S&P BSE SENSEX is up 5.2% over the year.

Current Valuations

At the current price of Rs 1,401.3, the price to earnings (P/E) ratio of GSK PHARMA stands at 58.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 11.5 times.

Equitymaster requests your view! Post a comment on "GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0%". Click here!

  

Related Views on News

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 235.3% (Quarterly Result Update)

Jul 26, 2018 | Updated on Jul 26, 2018

For the quarter ended June 2018, GSK PHARMA has posted a net profit of Rs 886 m (up 235.3% YoY). Sales on the other hand came in at Rs 7 bn (up 21.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

This is Why You Need to Buy Small Cap Stocks Now(The 5 Minute Wrapup)

Mar 15, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Mar 20, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE GSK PHARMA WITH

MARKET STATS